Latanoprost Stada (Latanoprost)

Latanoprost mimics prostaglandin F2α and binds to FP receptors in the eye’s ciliary body. This binding enhances the uveoscleral outflow pathway, allowing aqueous humor to drain more efficiently and thereby reducing intra‑ocular pressure.

The dosing regimen for Latanoprost Stada is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily, often in the evening, but exact instructions should follow the prescriber’s order.

Safety data for latanoprost in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by the treating physician.

To request Latanoprost Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and a favorable efficacy profile compared with beta‑blockers such as timolol. While both lower intra‑ocular pressure, prostaglandin analogues often achieve greater pressure reduction with fewer systemic side effects.

Latanoprost Stada should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from moisture and direct sunlight. Do not freeze the product, and keep the cap tightly closed when not in use.

Instill one drop of Latanoprost Stada into the conjunctival sac of the affected eye(s) once daily, preferably in the evening. Tilt the head back, pull down the lower eyelid to create a pocket, and avoid touching the tip of the bottle to the eye or any surface.

Serious adverse reactions, although rare, include uveitis, corneal edema, severe allergic responses, and paradoxical elevation of intra‑ocular pressure. Patients should seek immediate medical attention if they experience intense eye pain, vision changes, or signs of infection.

Latanoprost Stada is contraindicated in individuals with known hypersensitivity to latanoprost or any excipients, and in patients with active ocular inflammation such as uveitis. Caution is also advised for those with a history of severe allergic eye reactions.